The patent for one dollar
Banting, Best and Collip sold the insulin patent to the University of Toronto for one dollar each so that the treatment would be widely available.
MHI 078 · Exhibition
1921–1922
Documented dateToronto, Canada
Plate 078
1921–1922
Toronto, Canada
Frederick Banting and Charles Best began experiments in Toronto in 1921. The first patient, Leonard Thompson, was treated in January 1922.
Banting and Macleod received the Nobel Prize in 1923; Banting shared his money with Best and Macleod with Collip. Credit among the team has been argued ever since.
The world before
A diagnosis of type 1 diabetes meant a starvation diet and death, often of children, within a year or two.
The human achievement
Banting and Best isolated extracts from dog pancreas that lowered blood sugar. Collip purified it for human use. Leonard Thompson, 14, improved after injections in 1922. Eli Lilly began mass production in 1923.
Understanding the invention
Insulin, explained in two steps.
Step 01 of 02
Insulin lets cells take up sugar from blood. Without it, sugar builds up in the blood and cells starve.
IV
The transformation
Children near death recovered.
Opened the way to hormone and biologic drugs.
It turned a fatal disease into a manageable condition and became a model for hormone treatment.
Before and after
Before
Death within months.
After
A life with daily injections.
On larger screens, drag the divider (or use the arrow keys) to give more room to the world before or after.
VI
Its legacy
MHI 078
Insulin
Beyond the collection
Recombinant insulin
In 1978 human insulin was made in bacteria; sold from 1982.
Beyond the collection
Biotechnology
The first genetically engineered drug.
Human stories
Banting, Best and Collip sold the insulin patent to the University of Toronto for one dollar each so that the treatment would be widely available.
Where accounts differ, this museum follows the documented record and says so.
Next in the museum
Related exhibitions